Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03796806 · ClinicalTrials.gov registry record
Methods Validation Assessment for Study of Inflammatory Skin Disease
A clinical trial of Lichen Planus, sponsored by Mayo Clinic.
- Completed
- Registry status
- 1
- Enrollment target
- 1
- Study location
NCT03796806: Completed study of Lichen Planus, sponsored by Mayo Clinic.
NCT03796806 is a study of Lichen Planus that has completed, run by Mayo Clinic. The registered enrollment target is 1 participants, below the 142-participant average among 3 other Lichen Planus trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03796806, a study of Lichen Planus, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 1 participants
- Enrollment target
- 1
- Study location
Study Summary
1. Assess validity of methods involved in molecular studies of the skin in inflammatory skin disease 2. Assess feasibility of methods for grafting fresh human skin (normal and diseased with inflammatory skin disease) onto an established xenograft murine model.
Primary Outcome
Identification and quantification of proteins as obtained by liquid chromatography-mass spectrometry methods using fresh and formalin-fixed-paraffin-embedded tissue. Mass spectrometry data will be matched against a composite protein sequence database using the MyriMatch search engine and IDPicker will filter protein identification at 2% false discovery rate. QuasiTel software will process the spectral count data for the identification of differentially expressed proteins.
Conditions Studied
Study Locations (1)
Minnesota
- Mayo Clinic in Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2019-01-14 |
| Est. Completion | 2019-01-14 |
What the finished NCT03796806 record still lists
NCT03796806 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 1 participants, a relatively small participant target, below the 142-participant average among 3 other Lichen Planus trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Lichen Planus appearing as the primary indexed condition, and to 0 interventions.
NCT03796806 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT03796806 about?
NCT03796806 is a clinical study titled "Methods Validation Assessment for Study of Inflammatory Skin Disease". 1. Assess validity of methods involved in molecular studies of the skin in inflammatory skin disease 2. Assess feasibility of methods for grafting fresh human skin (normal and diseased with inflammatory skin disease) onto an established xenograft murine model.
What is the current status of trial NCT03796806?
This trial is currently completed. The enrollment target is 1 participants. The study started on 2019-01-14. Estimated completion is 2019-01-14.
What conditions does trial NCT03796806 study?
This clinical trial studies the following conditions: Lichen Planus.
Who is sponsoring clinical trial NCT03796806?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03796806 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lichen Planus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Widefield Fluorescence and Reflectance Imaging Systems and Oral Tissue Samples in Monitoring Participants at Risk for Developing Oral Cancer
ACTIVE NOT RECRUITING · NA
-
Ixekizumab in Adult Patients With Lichen Planus and Lichen Planopilaris
COMPLETED · Early Phase 1
-
Biomarkers for Oral Cancer
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI